TrialFrontiers in pharmacology2026

Durable responses to long-term selumetinib in Chinese pediatric NF1 patients with inoperable plexiform neurofibromas.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.